Branched Chain Amino Acid Plus Glucose Supplement Reduces Exercise-Induced Delayed Onset Muscle Soreness in College Females
Information source: University of Vermont
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Exercise-induced Delayed Onset Muscle Soreness
Intervention: Branched Chain Amino Acid drink supplement (Dietary Supplement); Placebo (Dietary Supplement)
Phase: N/A
Status: Completed
Sponsored by: University of Vermont Official(s) and/or principal investigator(s): Stephen J Pintauro, Ph.D., Principal Investigator, Affiliation: University of Vermont
Summary
The purpose of this study is to determine if a dietary supplement containing branched chain
amino acids will reduce the muscle soreness that sometimes occurs in the days following
exercise.
Clinical Details
Official title: The Effects of Branched Chain Amino Acid and Nutrient Supplementation on Exercise-Induced Delayed Onset Muscle Soreness in College Females
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
Primary outcome: Delayed Onset Muscle Soreness Rating Scale
Detailed description:
Supplementation with branched chain amino acids (BCAAs) has been used to stimulate muscle
protein synthesis following exercise. The purpose of this study was to determine if
supplementation with BCAAs in combination with glucose would reduce exercise-induced delayed
onset muscle soreness (DOMS). Using a double-blind crossover design, 20 subjects (11
females, 9 males) were randomly assigned to either BCAA (n=10) or placebo (n=10) groups.
Subjects performed a squatting exercise to elicit DOMS and rated their muscle soreness every
24 hours for four days following exercise while continuing to consume the BCAA or placebo.
Following a three-week recovery period, subjects returned and received the alternate BCAA or
placebo treatment, repeating the same exercise and DOMS rating protocol for the next four
days. BCAA supplementation in female subjects resulted in a significant decrease in DOMS
versus placebo at 24 hours following exercise (p = 0. 018). No significant effect of BCAA
supplementation versus placebo was noted in male subjects, nor when male and female results
were analyzed together. This gender difference may be related to dose per body weight
differences between male and female subjects.
Eligibility
Minimum age: 18 Years.
Maximum age: 25 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Men (n=9) and women (n=11) aged 18-25 who engaged in no more than one hour of light
to moderate intensity physical activity per week were recruited from the Greater
Burlington, Vermont area.
Exclusion Criteria:
- individuals who engaged in more than one hour per week of light to moderate physical
activity
- had been involved in strict athletic competition or weight training in the past six
months
- were pregnant or nursing, had a known muscular disease, diabetes mellitus,
cardiovascular disease, respiratory disease, and/or were currently taking a
protein-based dietary supplement
Locations and Contacts
University of Vermont, Burlington, Vermont 05405, United States
Additional Information
Starting date: September 2011
Last updated: January 31, 2013
|